Identification and validation of AFAP1L1 as an immune-related prognostic biomarker in clear cell renal cell carcinoma
AFAP1L1 may impact the ccRCC development and progression, acting as an immune-related prognostic marker for ccRCC.
Authors
- Yuewen Si
- Zijian Ye
- Yang Yu (ORCID: https://orcid.org/0000-0001-8388-5825)
- Luo Xuegang
- Biao Xie
- W.K. Wu
- Qiaoping Yan
- Yuan Zhang
- Qingming Zhang
Institutions
- Chongqing Maternal and Child Health Hospital (CN)
- Chongqing Public Health Medical Center (CN)
- Children's Hospital of Chongqing Medical University (CN)
- Chongqing Municipal Health Commission (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Biomarkers
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1080/1354750x.2026.2630072
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00